Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman diseaseDavid C. Fajgenbaum, Thomas S. Uldrick|Journal of Clinical Investigation|2019Cited by 138
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapyThomas S. Uldrick, Sharon R. Lewin, Rémi Fromentin et al.|Science Translational Medicine|2022Cited by 101